http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006229354-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35de055feb1cf224ec5511844f83ea4e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 |
| filingDate | 2005-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42dd30b3ceab64b87d3732af80123376 |
| publicationDate | 2006-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2006229354-A1 |
| titleOfInvention | Use of Isatin in stimulating red blood cell production and treatment of anemia |
| abstract | The present invention concerns small chemical compounds—Isatin and its derivatives, and a novel, safer and more convenient methods for the treatment of anemia resulting from various underlying conditions or diseases. The invention provides new methods to stimulate red cell production, and the new methods to prevent the development of anemia. The invention provides a new therapeutic approach for the treatment of chronic anemia patients, anemia patients who are receiving bone marrow suppressive therapies, HIV/AIDS patients who develop anemia upon the treatment of anti-retroviral therapies or from underlying disease itself, and anemia with other causes. The invention also provides methods for preventing anemia in many relatively healthy people such as young women who loss blood from menstrual blood. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102875445-A |
| priorityDate | 2005-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 154.